Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony- stimulating factor

Molecular and Cellular Biology

Volumn 20, Issue 8, 2000, Pages 2734-2742

  Lin, Yi Hung ^a,b   Huang, Chang Jen ^c   Chao, Jyh Rong ^b   Chen, Shui Tsung ^c   Lee, Shern Fwu ^d   Yen, Jeffrey Jong Young ^d   Yang Yen, Hsin Fang ^a,b  

^a ACADEMIA SINICA   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 3; OSTEOPONTIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN SECRETION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; CELL SURVIVAL; CHO CELLS; CRICETINAE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MICE; OSTEOPONTIN; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 0034069657     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.8.2734-2742.2000     Document Type: Article

References (66)

1. Arai, K., F. Lee, A. Miyajima, N. Arai, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783-836.
2. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1900. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
3. Ayroldi, E., L. Cannarile, G. Migliorati, A. Bartoli, I. Nicoletti, and C. Riccardi. 1995. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672-2678.
4. Azam, M., H. Erdjument-Bromage, B. L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J. N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 14:1402-1411.
5. Behrend, E. I., A. M. Craig, S. M. Wilson, D. T. Denhardt, and A. F. Chambers. 1994. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA. Cancer Res. 54:832-837.
6. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
7. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
8. Chao, J.-R., J.-M. Wang, S.-F. Lee, H.-W. Peng, Y.-H. Lin, C.-H. Chou, J.-C. Li, H.-M. Huang, C.-K. Chou, M.-L. Kuo, J. J.-Y. Yen, and H.-F. Yang-Yen. 1998. mcl-l is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol. Cell. Biol. 18:4883-4898.
9. Conscience, J. F., B. Verrier, and G. Martin. 1986. Interleukin-3-dependent expression of the c-myc and c-fos proto-oncogenes in hemopoietic cell lines. EMBO J. 5:317-323.
10. Corey, S., A. Eguinoa, K. Puyana-Theall, J. B. Bolen, L. Cantley, F. Mollinedo, T. R. Jackson, P. T. Hawkins, and L. R. Stephens. 1993. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3-OH-kinase and src-related tyrosine kinase(s) in human mycloid derived cells. EMBO J. 12:2681-2690.
11. Crawford, H. C., L. M. Matrisian, and L. Liaw. 1998. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res. 58:5206-5215.
12. Denhardt, D. V., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB J. 7:1475-1482.
13. Du, K., and M. Montminy. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273:32377-32379.
14. Duronio, V., I. Clark-Lewis, B. Federsppiel, J. S. Wieler, and J. W. Schrader. 1992. Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 267:21856-21863.
15. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
16. Gardner, H. A., B. Berse, and D. R. Senger. 1994. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 9:2321-2326.
17. Gold, M. R., V. Duronio, S. P. Saxena, J. W. Schrader, and R. Aebersold. 1994. Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J. Biol. Chem. 269:5403-5412.
18. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991 A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24.
19. Hanazono, Y., S. Chiba, K. Sasaki, H. Mann, A. Miyajima, K. Arai, Y. Yazaki, and H. Hirai. 1993. c-Fps/Fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12:1641-1646.
20. Heffernan, M., and J. W. Dennis. 1991. Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells. Nucleic Acids Res. 19:85-92.
21. Howie, S. E., A. J. Sommerfield, E. Gray, and D. J. Harrison. 1994. Peripheral T lymphocyte depletion by apoptosis after CD4 ligation in vivo: selective loss of CD44-and 'activating' memory T cells. Clin. Exp. Immunol. 95: 195-200.
22. Hu, D. D., E. C. Lin, N. L. Kovach, J. R. Hoyer, and J. W. Smith. 1995. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5, J. Biol. Chem. 270:26232-26238.
23. Jalkanen, S., S. Saari, H. Kalimo, K. Lammintausta, E. Vainio, R. Leino, A. M. Duijvestijn, and K. Kalimo. 1990. Lymphocyte migration into the skin: the role of lympocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J. Investig. Dermatol. 94:786-792.
24. Kane, L. P., V. S. Shapiro, D. Stokoe, and A. Weiss. 1999. Induction of NF-KB by the Akt/PKB kinase. Curr. Biol. 9:601-604.
25. Katagiri, Y. U., J. Sleeman, H. Fujii, P. Herrlich, H. Hotta, K. Tanaka, S. Chikuma, H. Yagita, K. Okumura, M. Murakami, I. Saiki, A. F. Chambers, and T. Uede. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59:219-226.
26. Kincade, P. W., Z. Zheng, S. Katoh, and L. Hanson. 1997. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9:635-642.
27. Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima. 1995. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 14:266-275.
28. Lesley, J., J. R. Hyman, and P. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
29. Leverrier, Y., J. Thomas, G. R. Perkins, M. Mangeney, M. K. L. Collins, and J. Marvel. 1997. In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways. Oncogene 14:425-430.
30. Liaw, L., D. E. Birk, C. B. Ballas, J. S. Whitsitt, J. M. Davidson, and B. L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J. Clin. Investig. 101:1468-1478.
31. Meredith, J. E., B. Fazeli, and M. A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4:953-961.
32. Miyajima, A., A. L.-F. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5. Blood 82:1960-1974.
33. Miyauchi, A., J. Alvarez, E. M. Greenfield, A. Teti, M. Grano, S. Colucci, A. Zambonin-Zallone, F. P. Ross, S. L. Teitelbaum, and D. Cheresh. 1991. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266:20369-20374.
34. Miyazaki, Y., M. Setoguchi, S. Yoshida, Y. Higuchi, S. Akizuki, and S. Yamamoto. 1990. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J. Biol. Chem. 265:14432-14438.
35. Mui, A. L.-F., H. Wakao, A. M. O'Farrell, N. Harada, and A. Miyajima. 1995. Interleukin-3, granulocyte-macrophage colony-stimulating factor and interleukin-5 transduce signals through two STAT5 homologues. EMBO J. 14: 1166-1175.
36. Oates, A. J., R. Barraclough, and P. S. Rudland. 1996. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13:97-104.
37. Ono, M., T. Yamamoto, and M. Nose. 1995. Allelic difference in the nucleotide sequence of the Eta-1/Op gene transcript. Mol. Immunol. 32:447-448.
38. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and B. B. Donner. 1999. NF-KB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
39. Packham, G., E. L. White, C. M. Eischen, H. Yang, E. Parganas, J. N. Ihle, D. A. Grillot, G. P. Zambetti, G. Nunez, and J. L. Cleveland. 1998. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev. 12:2475-2487.
40. Picker, L. J., L. W. Terstappen, L. S. Rott, P. R. Streeter, H. Stein, and E. C. Butcher. 1990. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J. Immunol. 145:3247-3255.
41. Quelle, F. W., N. Sato, B. A. Witthuhn, R. C. Inhorn, M. Eder, A. Miyajima, J. D. Griffin, and J. N. Ihle. 1994. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:4335-4341.
42. Rittling, S. R., H. N. Matsumoto, M. D. McKee, A. Nanci, X. R. An, K. E. Novick, A. J. Kowalski, M. Noda, and D. T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13:1101-1111.
43. Rodan, G. A. 1995. Osteopontin overview. Ann. N. Y. Acad. Sci. 760:1-5.
44. Rodriguez-Tarduchy, G., M. Collins, and A. Lopez-Rivas. 1990. Regulation of apoptosis in interleukin 3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J. 9:2997-3002.
45. Romashkova, J. A., and S. S. Makarov. 1999. NF-KB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
46. Ross, F. P., J. Chappel, J. I. Alvarez, D. Sander, W. T. Butler, M. C. Farach-Carson, K. A. Mintz, P. G. Robey, S. L. Teitelbaum, and D. A. Cheresh. 1993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate hone resorption. J. Biol. Chem. 268:9901-9907.
47. Salmi, M., and S. Jalkanen. 1991. Regulation of lymphocyte traffic to mucosaassociated lymphatic tissues. Gastroenterol Clin. N. Am. 20:495-510.
48. Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993 Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12:4181-4189.
49. Scatena, M., M. Almeida, M. L. Chaisson, N. Fausto, R. F. Nicosia, C. M. Giachelli, and M. Scatena. 1998. NF-KB mediates αvβ3 integrin-induced endothclial cell survival. J. Cell Biol. 141:1083-1093.
50. Scheid, M. P., R. W. Lauener, and V. Duronio. 1995. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony-stimulating factor. Biochem J. 312:159-162.
51. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, C. Furlonger, A. Zakarian, J. J. L. Simard, P. S. Ohashi, C. J. Paige, J. C. Gutierrez-Ramos, and T. W. Mak. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217-2233.
52. Seiter, S., R. Arch, S. Reber, D. Komitowski, M. Hofmann, H. Ponta, P. Herrlich, S. Matzku, and M. Zoller. 1993. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 177:443-455.
53. Sells, M. A., and J. Chernoff. 1995. Epitope-tag vectors for eukaryotic protein production. Gene 152:187-189.
54. Senger, D. R., C. A. Perruzzi, C. F. Gracey, A. Papadopoulos, and D. G. Tenen. 1988. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res. 48:5770-5774.
55. Silvennoinen, O., B. Witthuhn, F. W. Quelle, J. L. Cleveland, T. Yi, and J. N. Ihle. 1993. Structure of the Jak2 protein tyrosine kinase and its role in IL-3 signal transduction. Proc. Natl. Acad. Sci. USA 90:8429-8433.
56. Songyang, Z., D. Baltimore, L. C. Cantley, D. R. Kaplan, and T. F. Franke. 1997. Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:11345-11350.
57. Su, L., A. B. Mukherjee, and B. B. Mukherjee. 1995. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 10:2163-2169.
58. Sy, M.-S., Y.-J. Kuo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859-866.
59. (2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur. J. Immunol. 23:439-446.
60. Wang, J.-M., J.-R. Chao, W. Chen, M.-L. Kuo, J. J.-Y. Yen, and H.-F. Yang-Yen. 1999. The anti-apoptotic gene mcl-l is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 19:6195-6206.
61. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512.
62. Yen, J. J.-Y., Y. C. Hsieh, C. L. Yen, C. C. Chang, S. Lin, and H.-F. Yang-Yen. 1995. Restoring the apoptosis suppression response to IL-5 confers on erythroleukemic cells a phenotype of IL-5-dependent growth. J. Immunol. 154: 2144-2152.
63. Yoshimura, A., T. Ohkubo, T. Kiguchi, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, T. Hara, and A. Miyajima. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:2816-2826.
64. Yu, Q., B. P. Toole, and I. Stamenkovic. 1997. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. Exp. Med. 186:1985-1996.
65. Zha, J., H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell 87:619-628.
66. Zhou, T., C. K. Edwards III, and J. D. Mountz. 1995. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J. Exp. Med. 182: 129-137.